We previously reported that MARCH8 inhibits virus infection by downregulating HIV-1 envelope glycoprotein (HIV-1 Env) and vesicular stomatitis virus G-glycoprotein (VSV-G) from the surface of virus-producing cells, preventing their incorporation into virions. Here, ERVW-1 is linked to viral infectious disease.